Clinical Trial Update: Electrical Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating electrical cardioversion, ablation, or pacing strategies for persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Eastbourne General Hospital | Conditions: Persistent Atrial Fibrillation | Phase 4 | Status: COMPLETED